Colgate-Palmolive (NYSE:CL) Shares Sold by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. trimmed its position in Colgate-Palmolive (NYSE:CL) by 1.7% in the 4th quarter, HoldingsChannel reports. The firm owned 20,559 shares of the company’s stock after selling 350 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in Colgate-Palmolive were worth $1,869,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. D Orazio & Associates Inc. grew its holdings in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after acquiring an additional 108 shares during the period. Fiducient Advisors LLC increased its holdings in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in shares of Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after purchasing an additional 113 shares during the period. Waldron Private Wealth LLC boosted its holdings in Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after buying an additional 118 shares in the last quarter. Finally, Commonwealth Financial Services LLC increased its holdings in Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after buying an additional 118 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

CL stock opened at $87.05 on Tuesday. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The business has a fifty day moving average of $91.35 and a two-hundred day moving average of $97.15. The stock has a market cap of $71.12 billion, a price-to-earnings ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company earned $0.87 EPS. As a group, research analysts anticipate that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CL shares. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Morgan Stanley lowered their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday. Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.